How to take tirzepatide for weight loss: a practical guide

Which body site do you inject tirzepatide into, and does it matter?

Three sites are licensed for tirzepatide injections: the abdomen (stomach area, avoiding the two inches around the navel), the front of the thigh, and the outer upper arm. All three are subcutaneous, into the fat just beneath the skin, not into muscle. The abdomen is often easiest to reach yourself, but the thigh works well too, especially if you find the arm awkward without help.

Rotating sites is important. Injecting into the same spot week after week can cause localised tissue changes that affect how reliably the medicine is absorbed. A simple pattern (left thigh one week, right abdomen the next, for example) keeps the skin healthy. Avoid areas that are bruised, broken, red or hardened.

Wipe the chosen site with an alcohol swab and let it dry fully before injecting. Injecting through wet skin stings more and introduces a small contamination risk. Once dry, pinch a fold of skin gently, insert the needle at the angle described in the leaflet, press the button until you hear a click, and hold for ten seconds before removing. The pen locks automatically after use, a reassurance that the full dose was delivered.

For a full walkthrough of the injection mechanics and troubleshooting common errors, the Mounjaro injection guide covers each step in detail.

What does the dose schedule actually look like in practice?

Tirzepatide treatment opens at 2.5 mg. That first pen's job is to let your body adjust, the gastrointestinal effects that some people experience (nausea, loose stools, reflux) are typically worst in the early weeks, and the 2.5 mg starting point is calibrated to reduce them. Your prescriber moves the dose up, generally in four-week steps, through 5, 7.5, 10, 12.5 and up to 15 mg if tolerated and clinically appropriate.

Each pen is pre-loaded; the dose is fixed. You do not dial or draw anything up. One pen covers four weekly doses at that strength, then you move to the next. Your prescriber decides both the pace of titration and the maintenance dose, that decision involves your response, your side-effect profile and your health picture as a whole. Do not increase your dose early because you feel ready; do not delay an increase without speaking to your prescriber.

If you want background on how the medicine works alongside the dosing structure, our guide to tirzepatide as a weight loss pen explains the mechanism clearly. For cost context while you plan ahead, this page on Mounjaro pricing in the UK sets out what private treatment typically involves.

How should you store tirzepatide, and what happens if a pen gets too warm?

Tirzepatide pens are refrigerated at 2–8 °C from the moment they leave the pharmacy. Keep them in the fridge door, consistent cool temperature, away from the freezer section. Freezing destroys the medicine; a frozen-then-thawed pen should not be used.

There is a permitted window for room-temperature storage, which applies once you have removed the pen from the fridge. The exact duration and conditions for that window are specified in the Mounjaro SmPC and your Patient Information Leaflet. Look there, not at general websites, the window is shorter than most people assume, and the consequences of using heat-damaged medicine are real. If you are unsure whether a pen has been stored correctly, contact our clinical team rather than injecting and hoping.

Used pens are sharps waste. Recap the needle cover immediately after use and dispose of the pen in a sealed sharps container, never in household recycling or a bin bag. Local councils and pharmacies run sharps collection schemes; your prescriber or our aftercare team can advise on your nearest option.

For questions about travelling with tirzepatide, keeping it cool during transit or flying with injections, our frequently asked questions page has practical detail.

What side effects should prompt you to contact a prescriber, rather than waiting it out?

Most people on tirzepatide experience some GI effects, nausea leading the list, followed by loose stools, constipation in some cases, reflux and burping. These tend to be strongest in the days after a new or increased dose and settle as the body adjusts. Eating smaller meals, avoiding fatty or very rich food and staying hydrated all help. If you would like practical guidance on how to take Mounjaro for weight loss, including advice on timing, diet and managing early effects, our dedicated page brings it all together clearly.

Some symptoms need prompt attention. Severe stomach pain that radiates through to the back (with or without vomiting) can signal pancreatitis. The MHRA highlighted acute pancreatitis as a known, serious risk in its January 2026 Drug Safety Update for GLP-1 medicines; do not wait to see if it passes. Persistent vomiting that stops you keeping fluids down, signs of an allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat), or significant mood changes are all reasons to seek medical help the same day.

You can report any suspected side effect (however minor) through the MHRA Yellow Card scheme. It is open to patients as well as clinicians, and every report helps build the post-market safety picture for newer medicines like tirzepatide, which carries a Black Triangle (▼) status meaning active monitoring is ongoing.

Our prescribers are available seven days a week through aftercare if something is worrying you between reviews. If you are not yet on treatment and want to understand whether tirzepatide is right for your situation, you can read more about weight loss injections using tirzepatide as a good place to start alongside speaking to our prescribers.